GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Price-to-Tangible-Book

Enzymotec (Enzymotec) Price-to-Tangible-Book : 2.10 (As of Apr. 26, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Price-to-Tangible-Book?

As of today (2024-04-26), Enzymotec's share price is $11.85. Enzymotec's Tangible Book per Share of Sep. 2017 for the quarter that ended in Sep. 2017 was $5.64. Hence, Enzymotec's Price to Tangible Book Ratio of today is 2.10.

The historical rank and industry rank for Enzymotec's Price-to-Tangible-Book or its related term are showing as below:

ENZY's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.67
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Enzymotec's share price is $11.85. Enzymotec's Book Value per Sharefor the quarter that ended in Sep. 2017 was $5.95. Hence, Enzymotec's P/B Ratio of today is 1.99.


Enzymotec Price-to-Tangible-Book Historical Data

The historical data trend for Enzymotec's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Price-to-Tangible-Book Chart

Enzymotec Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Price-to-Tangible-Book
Get a 7-Day Free Trial - 4.95 1.35 1.64 1.10

Enzymotec Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.15 1.10 1.50 1.40 2.04

Competitive Comparison of Enzymotec's Price-to-Tangible-Book

For the Biotechnology subindustry, Enzymotec's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymotec's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzymotec's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Enzymotec's Price-to-Tangible-Book falls into.



Enzymotec Price-to-Tangible-Book Calculation

Enzymotec's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2017 )
=11.85/5.639
=2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Enzymotec Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Enzymotec's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymotec (Enzymotec) Business Description

Traded in Other Exchanges
N/A
Address
Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016